185 related articles for article (PubMed ID: 10803634)
41. Transient elastography predicts fibrosis progression in patients with recurrent hepatitis C after liver transplantation.
Rigamonti C; Donato MF; Fraquelli M; Agnelli F; Ronchi G; Casazza G; Rossi G; Colombo M
Gut; 2008 Jun; 57(6):821-7. PubMed ID: 18218676
[TBL] [Abstract][Full Text] [Related]
42. Progression of liver fibrosis in patients with chronic hepatitis C after orthotopic liver transplantation.
Chopra KB; Demetris AJ; Blakolmer K; Dvorchik I; Laskus T; Wang LF; Araya VR; Dodson F; Fung JJ; Rakela J; Vargas HE
Transplantation; 2003 Nov; 76(10):1487-91. PubMed ID: 14657691
[TBL] [Abstract][Full Text] [Related]
43. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.
Burra P; Loreno M; Russo FP; Germani G; Galligioni A; Senzolo M; Cillo U; Zanus G; Fagiuoli S; Rugge M
Liver Transpl; 2009 Jun; 15(6):619-28. PubMed ID: 19479805
[TBL] [Abstract][Full Text] [Related]
44. Cirrhosis of mixed etiology (hepatitis C virus and alcohol): Posttransplantation outcome-Comparison with hepatitis C virus-related cirrhosis and alcoholic-related cirrhosis.
Aguilera V; Berenguer M; Rubín A; San-Juan F; Rayón JM; Prieto M; Mir J
Liver Transpl; 2009 Jan; 15(1):79-87. PubMed ID: 19109849
[TBL] [Abstract][Full Text] [Related]
45. The impact of nonalcoholic fatty liver disease and the metabolic syndrome on progression of fibrosis in patients with recurrent HCV after liver transplantation.
Mindikoglu AL; Regev A; Casanova-Romero PY; Bejarano PA; Martinez EJ; Tzakis AG; Schiff ER
Transplant Proc; 2006 Jun; 38(5):1440-4. PubMed ID: 16797327
[TBL] [Abstract][Full Text] [Related]
46. Hepatitis C virus-related cirrhosis as a significant mortality factor in intention-to-treat analysis in liver transplantation.
Gringeri E; Vitale A; Brolese A; Zanus G; Boccagni P; Neri D; Valmasoni M; D'Amico F; Ciarleglio FA; Carraro A; Pauletto A; Violi P; Bassi D; D'Amico F; D'Amico DF; Cillo U
Transplant Proc; 2007; 39(6):1901-3. PubMed ID: 17692648
[TBL] [Abstract][Full Text] [Related]
47. An economic analysis of antiviral therapy in patients with advanced hepatitis C virus disease: still not there!
Rubin A; Berenguer M
Liver Transpl; 2010 Jun; 16(6):697-700. PubMed ID: 20517902
[No Abstract] [Full Text] [Related]
48. [The course of hepatitis C infection after liver transplantation].
Ołdakowska-Jedynak U; Paczek L
Pol Merkur Lekarski; 2005 Aug; 19(110):220-4. PubMed ID: 16245439
[TBL] [Abstract][Full Text] [Related]
49. Liver transplantation for hepatitis C: recurrence and disease progression in 300 patients.
Testa G; Crippin JS; Netto GJ; Goldstein RM; Jennings LW; Brkic BS; Brooks BK; Levy MF; Gonwa TA; Klintmalm GB
Liver Transpl; 2000 Sep; 6(5):553-61. PubMed ID: 10980053
[TBL] [Abstract][Full Text] [Related]
50. Chronic hepatitis C and liver transplantation.
Davis GL
Rev Gastroenterol Disord; 2004; 4(1):7-17. PubMed ID: 15029106
[TBL] [Abstract][Full Text] [Related]
51. Natural history and risk factors for progression of hepatitis C virus disease and development of hepatocellular cancer before liver transplantation.
Shiffman ML
Liver Transpl; 2003 Nov; 9(11):S14-20. PubMed ID: 14586890
[TBL] [Abstract][Full Text] [Related]
52. Prophylaxis and treatment of recurrent viral hepatitis after liver transplantation.
Riediger C; Berberat PO; Sauer P; Gotthardt D; Weiss KH; Mehrabi A; Merle U; Stremmel W; Encke J
Nephrol Dial Transplant; 2007 Sep; 22 Suppl 8():viii37-viii46. PubMed ID: 17890261
[TBL] [Abstract][Full Text] [Related]
53. Intra portal donor specific antigen transfusion might prevent re-infection of hepatitis C virus after living related liver transplantation in hepatitis C hepatic cirrhosis.
Sato Y; Oya H; Yamamoto S; Kobayashi T; Watanabe T; Kokai H; Yamagiwa S; Hatakeyama K
Hepatogastroenterology; 2009; 56(89):205-7. PubMed ID: 19453058
[TBL] [Abstract][Full Text] [Related]
54. HCV infection and liver transplantation.
Samuel D; Feray C; Bismuth H
Acta Gastroenterol Belg; 1997; 60(3):214-6. PubMed ID: 9396178
[TBL] [Abstract][Full Text] [Related]
55. Genotype 1b and severity of posttransplant recurrence of hepatitis C infection- unconvictable felon or wrongly accused?
Charlton M
Liver Transpl; 2000 Mar; 6(2):243-5. PubMed ID: 10719029
[No Abstract] [Full Text] [Related]
56. Transient elastography in the early prediction of progressive recurrent hepatitis C following liver transplantation.
Rigamonti C; Donato MF; Colombo M
Hepatology; 2010 Aug; 52(2):800-1. PubMed ID: 20683975
[No Abstract] [Full Text] [Related]
57. Non-invasive assessment of fibrosis in liver grafts due to hepatitis C virus recurrence.
J S Cross T; Jothimani D; Heneghan MA; Harrison PM
Clin Transplant; 2011; 25(3):345-51. PubMed ID: 21517974
[TBL] [Abstract][Full Text] [Related]
58. Angiotensin II antagonists in patients with recurrent hepatitis C virus infection after liver transplantation.
Cholongitas E; Vibhakorn S; Lodato F; Burroughs AK
Liver Int; 2010 Feb; 30(2):334-5. PubMed ID: 19515217
[No Abstract] [Full Text] [Related]
59. Liver transplantation for hepatitis C virus related cirrhosis.
Crosbie OM; Alexander GJ
Baillieres Best Pract Res Clin Gastroenterol; 2000 Apr; 14(2):307-25. PubMed ID: 10890324
[TBL] [Abstract][Full Text] [Related]
60. [Viral hepatitis C].
Giostra E; Cunningham M; Mentha G; Loizeau E
Rev Med Suisse Romande; 1992 Jun; 112(6):509-12. PubMed ID: 1631461
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
